
    
      After four months run-in with repaglinide plus metformin combination-therapy, patients with
      HemoglobinA1c â‰¥6.5% will be randomized (baseline=0 month) to repaglinide 2 mg thrice-daily or
      metformin 1g twice-daily, both in combination with BIAsp30 (30% insulin-aspart; 70%
      protaminated insulin-aspart) (6U once-daily, pre-dinner) for 12 months.
    
  